Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test
Dow Jones2026/09/24 16:22By Elias Schisgall
Shares of Grail rose after the healthcare company said a U.S. regulatory committee voted to approve its Galleri multi-cancer early detection test.
The stock was up 5.6% at $114.59 as of midday Thursday. Shares have risen 34% this year.
The company on Wednesday said a panel on the Food and Drug Administration's Medical Devices Advisory Committee voted to approve its premarket approval application for Galleri.
The panel voted seven to two with one abstention that the test's benefits outweigh its risks, six to four that the test was effective, and unanimously in support of its safety.
"Today's vote reinforces the strength of Galleri's clinical evidence. We believe the panel's recommendations reaffirm a high evidence bar that GRAIL has set for a multi-cancer early detection test," Grail Chief Executive Josh Ofman said. "GRAIL is committed to working with the FDA as it completes its review of Galleri, the first PMA submission for a multi-cancer early detection test."
Galleri received a breakthrough devices designation from the FDA in 2018. The company submitted its PMA application to the FDA early this year, and the agency is expected to make a final decision in the coming months.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
September 24, 2026 12:22 ET (16:22 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold Fields said to weigh sweetening Northern Star bid with cash
Under continuous pressure from inflation and interest rate hike concerns, US Treasury sell-off intensifies; 30-year yield once surpassed 5.6%, hitting a more than 24-year high
U.S. long-term Treasury yields continued to rise on Tuesday, extending the recent sharp upward trend.
The US releases the final batch of strategic oil reserves, up to 40 million barrels, urging Europe to follow suit.
This is the final batch of the 172 million barrels of reserves released by the United States in this round; after this release, the U.S. Strategic Petroleum Reserve will drop to its lowest level since 1982, approaching legal and operational red lines. Meanwhile, the U.S. Secretary of Energy criticized some European countries for releasing far less than expected, urging them to fulfill their commitments. Currently, gasoline and diesel prices in the U.S. remain high, and less than two months remain until the midterm elections. On Tuesday, WTI crude oil futures fell by 3.95%.
Raphael Zagury: Bitcoin will eventually surpass gold
Crypto prices
More
